Oxabispidine-derived ionizable lipids for effective mRNA delivery to the lungs using lipid nanoparticles
- 4 December 2025
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 24 (2) , 481-487
Abstract
LNPs prepared using a new class of ionizable lipids effectively and safely deliver mRNA to rat lungs via intratracheal or inhalation administration.Keywords
This publication has 40 references indexed in Scilit:
- Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosomeAdvanced Drug Delivery Reviews, 2024
- Spray dried lipid nanoparticle formulations enable intratracheal delivery of mRNAJournal of Controlled Release, 2023
- The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticlesJournal of Controlled Release, 2023
- Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical studyJournal of Cystic Fibrosis, 2023
- Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid‐Nanoparticle Components for Therapeutic and Vaccine ApplicationsAdvanced Materials, 2023
- Lipid nanoparticle-mediated mRNA delivery in lung fibrosisEuropean Journal of Pharmaceutical Sciences, 2023
- The role of lipid components in lipid nanoparticles for vaccines and gene therapyAdvanced Drug Delivery Reviews, 2022
- Branched‐Tail Lipid Nanoparticles Potently Deliver mRNA In Vivo due to Enhanced Ionization at Endosomal pHSmall, 2019
- A review on cationic lipids with different linkers for gene deliveryAdvances in Colloid and Interface Science, 2018
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012